Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hosford

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|May 19, 1989
Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusionM Koltai, A Tosaki, D Hosford, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Platelet-activating factor antagonists: scientific background and possible clinical applicationsM Koltai, P Guinot, D Hosford, et al.
Progress in Clinical and Biological Research|January 1, 1989
The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shockB Bonavida, M Paubert-Braquet, D Hosford, et al.
Drugs|August 1, 1991
PAF. A review of its effects, antagonists and possible future clinical implications (Part II)M Koltai, D Hosford, P Guinot, et al.
International Archives of Allergy and Applied Immunology|January 1, 1989
Role of cytokines and platelet-activating factor in microvascular immune injuryP Braquet, D Hosford, M Braquet, et al.
Drugs|July 1, 1991
Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I)M Koltai, D Hosford, P Guinot, et al.
Cardiovascular Research|May 1, 1991
Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat heartsM Koltai, A Tosaki, D Hosford, et al.
Journal of Lipid Mediators|January 1, 1990
Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteinsM Paubert-Braquet, D Hosford, P Klotz, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Platelet-activating factor amplifies tumour necrosis factor-induced superoxide generation by human neutrophilsM Paubert-Braquet, P Koltz, J Guilbaud, et al.
Lipids|December 1, 1991
Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteinsP Braquet, D Hosford, P Koltz, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|May 19, 1989
Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusionM Koltai, A Tosaki, D Hosford, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Platelet-activating factor antagonists: scientific background and possible clinical applicationsM Koltai, P Guinot, D Hosford, et al.
Progress in Clinical and Biological Research|January 1, 1989
The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shockB Bonavida, M Paubert-Braquet, D Hosford, et al.
Drugs|August 1, 1991
PAF. A review of its effects, antagonists and possible future clinical implications (Part II)M Koltai, D Hosford, P Guinot, et al.
International Archives of Allergy and Applied Immunology|January 1, 1989
Role of cytokines and platelet-activating factor in microvascular immune injuryP Braquet, D Hosford, M Braquet, et al.
Drugs|July 1, 1991
Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I)M Koltai, D Hosford, P Guinot, et al.
Cardiovascular Research|May 1, 1991
Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat heartsM Koltai, A Tosaki, D Hosford, et al.
Journal of Lipid Mediators|January 1, 1990
Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteinsM Paubert-Braquet, D Hosford, P Klotz, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Platelet-activating factor amplifies tumour necrosis factor-induced superoxide generation by human neutrophilsM Paubert-Braquet, P Koltz, J Guilbaud, et al.
Lipids|December 1, 1991
Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteinsP Braquet, D Hosford, P Koltz, et al.
Pageof 4